209 search results for “titel therapy” in the Staff website
-
Model-informed Design of Antibiotic Therapy against Antimicrobial Resistance
PhD defence
-
Erica Bohnen
Faculty of Social and Behavioural Sciences
bohnen@fsw.leidenuniv.nl | 071 5273381
-
Douwe AtsmaFaculty of Medicine
d.e.atsma@lumc.nl | 070 5262020
-
Developing new therapies to fight muscle disease
Biophysicist Alireza Mashaghi and his collaborators are taking up the fight against muscular dystrophy: genetic disorders that cause muscle weakness. They want to inhibit the clumping of proteins that results in toxic aggregates. For this, the team receives 550,000 euros from Health Holland. The team…
-
Jessy Terpstra
Faculty of Social and Behavioural Sciences
j.a.terpstra@fsw.leidenuniv.nl | 071 5272727
-
Rethinking antibiotic therapy of urinary tract infections
Suruchi Nepal, postdoc in the group of Coen van Hasselt at LACDR, was awarded an NWO XS project which aims to study the response to antibiotic treatment during a urinary tract infection (UTI). This knowledge will be used to determine how treatments of UTIs with antibiotics can be further improved.
-
Oncode Accelerator funds preclinical development of cancer therapies
Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.
-
LUMC signs international agreement on developing Advanced Therapy Medicinal Products
Skåne University Hospital, Lund University and Leiden University Medical Center will work together to expand their research, teaching and development relating to Advanced Therapy Medicinal Products. That is the essence of a Memorandum of Understanding signed at SciLifeLab near Stockholm on Wednesday…
-
Special nanoparticles for cancer therapy! Will you help?
Developing a better treatment for patients with head and neck cancer, that is what Binanox, The 2022 iGEM Leiden team, want to achieve. They hope to raise at least 10,000 euros for this cause. Support their crowdfunding campaign today.
-
A future with tailored therapy for patients with atherosclerosis
The AtheroNeth consortium received €6 million from the Dutch Heart Foundation to gain a better understanding of the differences in disease progression among patients with atherosclerosis. The ultimate goal is to enable personalised treatment.
-
Cevdet AcarsoyFaculty of Social and Behavioural Sciences
c.acarsoy@fsw.leidenuniv.nl | 071 5272727
-
patient in the Netherlands successfully treated with stem cell gene therapy
Researchers from the Leiden University Medical Center (LUMC) have successfully used stem cell gene therapy to treat a baby with the severe congenital immune disorder SCID. An important milestone: it is the first time stem cell gene therapy of Dutch origin has been administered to a patient, and also…
-
Marike KooistraFaculty of Social and Behavioural Sciences
m.j.kooistra@fsw.leidenuniv.nl | 071 5272727
-
Rianne de KleineFaculty of Social and Behavioural Sciences
r.a.de.kleine@fsw.leidenuniv.nl | 071 5275435
-
X-ray mirrors: useful in space, but also for radiation therapy
A special type of mirror to reflect X-rays has more possible applications than space research. Targeted radiation therapy for cancer, for example. Next to his full-time job, physicist David Girou mapped out the possibilities. He will receive his PhD on 14 June.
-
Johanna Greeven
Faculty of Social and Behavioural Sciences
greeven@fsw.leidenuniv.nl | 071 5272727
-
Thomas WillemsFaculty of Social and Behavioural Sciences
t.r.a.willems@fsw.leidenuniv.nl | 071 5272727
-
‘Exposure therapy’ for bachelor students: preparing for the reality of scientific research
Already during their bachelor’s programme, students in Pharmaceutical Sciences are presented with challenging projects. One of these is the Bachelor Research Assignment (BOO in Dutch), which is often their first real experience with scientific research. This means a lot of responsibility and failures,…
-
AMPK activation as host-directed therapy to improve tuberculosis treatment: Computational characterization and prediction of intracellular pharmacology
Rob van Wijk (LACDR, Leiden University) and Robin van den Biggelaar (LUCID, LUMC) have been awarded a €10,000 euro KIEM grant from Leiden University to start an interdisciplinary collaboration to investigate the potential of AMPK activation as an adjunctive therapy to enhance tuberculosis treatment.
-
Danielle OprelFaculty of Social and Behavioural Sciences
d.a.c.oprel@fsw.leidenuniv.nl | 071 5272727
-
Katja CardolFaculty of Social and Behavioural Sciences
c.k.cardol@fsw.leidenuniv.nl | 071 5275697
-
Femke Stad
Faculty of Social and Behavioural Sciences
f.e.stad@fsw.leidenuniv.nl | 071 5276790
-
Bianca BoyerFaculty of Social and Behavioural Sciences
b.e.boyer@fsw.leidenuniv.nl | 071 5272727
-
Judith BovéeFaculty of Medicine
j.v.m.g.bovee@lumc.nl | 071 5269111
-
Mara van OschFaculty of Social and Behavioural Sciences
m.van.osch@fsw.leidenuniv.nl | 071 5272727
-
Oana Georgiana Rus-OswaldFaculty of Social and Behavioural Sciences
o.g.rus@fsw.leidenuniv.nl | 071 5272727
-
Lioe-Fee de Geus-OeiFaculty of Medicine
l.f.de_geus-oei@lumc.nl | 071 5269111
-
David HeyneFaculty of Social and Behavioural Sciences
heyne@fsw.leidenuniv.nl | 071 5272727
-
Veronica Janssen
Faculty of Social and Behavioural Sciences
vjanssen@fsw.leidenuniv.nl | 071 5272727
-
Mona Shahab -
Leiden scientists join national effort to advance nanomedicine
A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University play a key role in the project.
-
Willem van der DoesFaculty of Social and Behavioural Sciences
vanderdoes@fsw.leidenuniv.nl | 071 5272727
-
Nina KomrijFaculty of Social and Behavioural Sciences
n.l.komrij@fsw.leidenuniv.nl | 071 5272727
-
Webinar Transfusion Medicine and Cellular and Tissue Therapies
Study information
-
Is a cancer pill a matter of time?
A cancer pill, preferably without severe side effects, is something we’d all welcome. Is it a matter of time before such a pill is a reality? We put this question to three Leiden researchers and asked how they themselves are contributing to new cancer treatments.
-
Philip SpinhovenFaculty of Social and Behavioural Sciences
spinhoven@fsw.leidenuniv.nl | 071 5272727
-
Sylvestre BonnetFaculty of Science
bonnet@chem.leidenuniv.nl | 071 5274260
-
Rick HaasFaculty of Medicine
r.l.m.haas@lumc.nl | 071 5269111
-
Eveline BleikerFaculty of Medicine
e.bleiker@nki.nl | 071 5268033
-
John HaanenFaculty of Medicine
j.haanen@nki.nl | 071 5263057
-
Jeroen JansenFaculty of Medicine
j.c.jansen@lumc.nl | 071 5269111
-
Marjanka SchmidtFaculty of Medicine
m.k.schmidt@lumc.nl | 071 5269111
-
Alfred VertegaalFaculty of Medicine
a.c.o.vertegaal@lumc.nl | 071 5269111
-
Health insurance
If you wish, you can take part in the collective health insurance scheme offered by Leiden University and Zorg en Zekerheid. This scheme offers a collective discount, for you and your family.
-
Joan Hendrik VeelkenFaculty of Medicine
j.h.veelken@lumc.nl | 071 5262267
-
Coen RaschFaculty of Medicine
c.r.n.rasch@lumc.nl |
-
Johanneke PortieljeFaculty of Medicine
j.e.a.portielje@lumc.nl | 071 5263464
-
Michiel van de SandeFaculty of Medicine
m.a.j.van_de_sande@lumc.nl | 071 5263606
-
Thorbald van HallFaculty of Medicine
t.van_hall@lumc.nl | 071 5266945
-
Jannie Keyser-BorstFaculty of Medicine
j.g.borst@lumc.nl |